Prospective multicenter comparison of models to predict four or more involved axillary lymph nodes in patients with breast cancer with one to three metastatic sentinel lymph nodes

Journal of Clinical Oncology

Volumn 27, Issue 34, 2009, Pages 5707-5712

  Werkoff, Gabrielle ^a   Lambaudie, Eric ^a   Fondrinier, Eric ^a   Levêque, Jean ^a   Marchal, Fréderic ^a   Uzan, Michele ^a   Barranger, Emmanuel ^a   Guillemin, François ^a   Darai, Emile ^a   Uzan, Serge ^a   Houvenaeghel, Gilles ^a   Rouzier, Roman ^a   Coutant, Charles ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CALIBRATION; CONTROLLED STUDY; FALSE NEGATIVE RESULT; HUMAN; HUMAN TISSUE; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; NOMOGRAM; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENTINEL LYMPH NODE; AXILLA; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY; STATISTICAL MODEL;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MODELS, STATISTICAL; NOMOGRAMS; SENTINEL LYMPH NODE BIOPSY;

EID: 73349090945     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2009.21.9139     Document Type: Article

References (54)

1. Foster RD, Hansen SL, Esserman LJ, et al: Safety of immediate transverse rectus abdominis myocutaneous breast reconstruction for patients with locally advanced disease. Arch Surg 140:196-198, 2005
2. Hanks SH, Lyons JA, Crowe J, et al: The acute effects of postoperative radiation therapy on the transverse rectus abdominis myocutaneous flap used in immediate breast reconstruction. Int J Radiat Oncol Biol Phys 47:1185-1190, 2000
3. Kronowitz SJ, Hunt KK, Kuerer HM, et al: Delayed-immediate breast reconstruction. Plast Reconstr Surg 113:1617-1628, 2004
4. Soong IS, Yau TK, Ho CM, et al: Postmastectomy radiotherapy after immediate autologous breast reconstruction in primary treatment of breast cancers. Clin Oncol (R Coll Radiol) 16:283-289, 2004
5. Zimmerman RP, Mark RJ, Kim AI, et al: Radiation tolerance of transverse rectus abdominis myocutaneous-free flaps used in immediate breast reconstruction. Am J Clin Oncol 21:381-385, 1998
6. Behranwala KA, Dua RS, Ross GM, et al: The influence of radiotherapy on capsule formation and aesthetic outcome after immediate breast reconstruction using biodimensional anatomical expander implants. J Plast Reconstr Aesthet Surg 59:1043-1051, 2006
7. Contant CM, van Geel AN, van der Holt B, et al: Morbidity of immediate breast reconstruction (IBR) after mastectomy by a subpectorally placed silicone prosthesis: The adverse effect of radiotherapy. Eur J Surg Oncol 26:344-350, 2000
8. Kronowitz SJ, Robb GL: Breast reconstruction with postmastectomy radiation therapy: Current issues. Plast Reconstr Surg 114:950-960, 2004
9. Rogers NE, Allen RJ: Radiation effects on breast reconstruction with the deep inferior epigastric perforator flap. Plast Reconstr Surg 109:1919-1924, 2002
10. Spear SL, Ducic I, Low M, et al: The effect of radiation on pedicled TRAM flap breast reconstruction: Outcomes and implications. Plast Reconstr Surg 115:84-95, 2005
11. Spear SL, Onyewu C: Staged breast reconstruction with saline-filled implants in the irradiated breast: Recent trends and therapeutic implications. Plast Reconstr Surg 105:930-942, 2000
12. Tran NV, Evans GR, Kroll SS, et al: Postoperative adjuvant irradiation: Effects on transverse rectus abdominis muscle flap breast reconstruction. Plast Reconstr Surg 106:313-317, 2000
13. Vandeweyer E, Deraemaecker R: Radiation therapy after immediate breast reconstruction with implants. Plast Reconstr Surg 106:56-58, 2000
14. Whitfield GA, Horan G, Irwin MS, et al: Incidence of severe capsular contracture following implant-based immediate breast reconstruction with or without postoperative chest wall radiotherapy using 40 Gray in 15 fractions. Radiother Oncol 90:141-147, 2009
15. Gebski V, Lagleva M, Keech A, et al: Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: A clinical perspective. J Natl Cancer Inst 98:26-38, 2006
16. Giordano SH, Kuo YF, Freeman JL, et al: Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97:419-424, 2005
17. Overgaard M, Hansen PS, Overgaard J, et al: Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337:949-955, 1997
18. Overgaard M, Jensen MB, Overgaard J, et al: Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353:1641-1648, 1999
19. Ragaz J, Jackson SM, Le N, et al: Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337:956-962, 1997
20. Rutqvist LE, Rose C, Cavallin-Stahl E: A systematic overview of radiation therapy effects in breast cancer. Acta Oncol 42:532-545, 2003
21. Van de Steene J, Soete G, Storme G: Adjuvant radiotherapy for breast cancer significantly improves overall survival: The missing link. Radiother Oncol 55:263-272, 2000
22. Whelan TJ, Julian J, Wright J, et al: Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18: 1220-1229, 2000
23. Recht A, Edge SB, Solin LJ, et al: Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1539-1569, 2001
24. Harris JR, Halpin-Murphy P, McNeese M, et al: Consensus Statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys 44:989-990, 1999
25. Chagpar AB, Scoggins CR, Martin RC 2nd, et al: Predicting patients at low probability of requiring postmastectomy radiation therapy. Ann Surg Oncol 14:670-677, 2007
26. Katz A, Smith BL, Golshan M, et al: Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer. J Clin Oncol 26:2093-2098, 2008
27. Barranger E, Coutant C, Flahault A, et al: An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91:113-119, 2005
28. Coutant C, Rouzier R, Fondrinier E, et al: Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: A prospective multicenter study. Breast Cancer Res Treat 113:537-543, 2009
29. Coutant C, Olivier C, Lambaudie E, et al: Comparison of models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: A prospective multicenter study. J Clin Oncol 27:2800-2808, 2009
30. Hanley JA, McNeil BJ: The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36, 1982
31. Cox D: Two further applications of a model for binary regression. Biometrika 45:562-565, 1958
32. Rouzier R, Pusztai L, Delaloge S, et al: Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancer. J Clin Oncol 23:8331-8339, 2005
33. Unal B, Gur S, Beriwal S, et al: Predicting the burden of axillary disease in breast cancer patients with a positive sentinel node. Presented at the 31st Annual San Antonio Breast Cancer Symposium, San Antonio, TX, December 10-14, 2008 (abstr 1010)
34. Leidenius M, Vaalavirta L, Heikkila P, et al: The prevalence of and risk factors for four or more metastatic axillary lymph nodes in breast cancer patients undergoing sentinel node biopsy. J Surg Oncol 98:21-26, 2008
35. Rouzier R, Pusztai L, Garbay JR, et al: Development and validation of nomograms for predicting residual tumor size and the probability of successful conservative surgery with neoadjuvant chemotherapy for breast cancer. Cancer 107:1459-1466, 2006
36. Locker GY, Sainsbury JR, Cuzick J: Breast surgery in the 'Arimidex, Tamoxifen Alone or in Combination' (ATAC) trial: American women are more likely than women from the United Kingdom to undergo mastectomy. Cancer 101:735-740, 2004
37. Nattinger AB, Hoffmann RG, Kneusel RT, et al: Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 356:1148-1153, 2000
38. Whelan T, Levine M: More evidence that locoregional radiation therapy improves survival: What should we do? J Natl Cancer Inst 97:82-84, 2005
39. Ceilley E, Jagsi R, Goldberg S, et al: Radiotherapy for invasive breast cancer in North America and Europe: Results of a survey. Int J Radiat Oncol Biol Phys 61:365-373, 2005
40. Katz A, Strom EA, Buchholz TA, et al: Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol 18:2817-2827, 2000
41. Recht A, Gray R, Davidson NE, et al: Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17:1689-1700, 1999
42. Taghian A, Jeong JH, Mamounas E, et al: Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22:4247-4254, 2004
43. Fowble B, Gray R, Gilchrist K, et al: Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 6:1107-1117, 1988
44. Marks LB, Hardenbergh P, Prosnitz LR: Mounting evidence for postmastectomy locoregional radiation therapy. Oncology (Williston Park) 13:1123-1135, 1999
45. Marks LB, Zeng J, Prosnitz LR: One to three versus four or more positive nodes and postmastectomy radiotherapy: Time to end the debate. J Clin Oncol 26:2075-2077, 2008
46. Olivotto IA, Truong PT, Chua B: Postmastectomy radiation therapy: Who needs it? J Clin Oncol 22:4237-4239, 2004
47. Early Breast Cancer Trialists' Collaborative Group: Favourable and unfavourable effects on longterm survival of radiotherapy for early breast cancer: An overview of the randomised trials. Lancet 355: 1757-1770, 2000
48. Cuzick J, Stewart H, Rutqvist L, et al: Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447-453, 1994
49. Clark RM, Whelan T, Levine M, et al: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for nodenegative breast cancer: An update - Ontario Clinical Oncology Group. J Natl Cancer Inst 88:1659-1664, 1996
50. Fisher B, Anderson S, Bryant J, et al: Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233-1241, 2002
51. Vinh-Hung V, Verschraegen C: Breast-conserving surgery with or without radiotherapy: Pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96:115-121, 2004
52. Ragaz J, Olivotto IA, Spinelli JJ, et al: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst 97:116-126, 2005
53. Truong PT, Olivotto IA, Kader HA, et al: Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 61:1337-1347, 2005
54. Cheng SH, Horng CF, Clarke JL, et al: Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Int J Radiat Oncol Biol Phys 64: 1401-1409, 2006